Mode
Text Size
Log in / Sign up

Meta-analysis finds vitamin D supplementation does not significantly affect ovarian reserve markers in womenVitamin D Supplements Won't Boost Your Fertility After All

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider that vitamin D supplementation may not improve ovarian reserve markers in women of reproductive age.

This is a meta-analysis synthesizing evidence on vitamin D supplementation and ovarian reserve, measured by serum anti-Müllerian hormone (AMH) levels, in women of reproductive age. The analysis pooled data from 992 participants and found no significant overall effect of vitamin D supplementation compared to placebo or no intervention on serum AMH levels (standardized mean difference [SMD] −0.20; 95% CI −0.48 to 0.08; p = 0.16).

Subgroup analyses indicated no significant effect in double-blind trials, but a reduction in AMH was observed in open-label trials (p for subgroup difference = 0.02). An interaction was noted by baseline AMH level, with a reduction in studies where baseline AMH was greater than 6 ng/mL (SMD −0.55; 95% CI −0.87 to −0.23; p = 0.003).

The authors acknowledge substantial heterogeneity (I² = 77%, p < 0.001) and note that findings should be interpreted cautiously. Safety data were not reported, and the certainty of evidence is moderate.

Practice relevance is not specified in the source. The analysis highlights gaps in trial design and baseline characteristics that may influence outcomes, but does not support routine vitamin D supplementation for improving ovarian reserve markers based on current evidence.

Researchers combined data from 992 women across 11 randomized controlled trials. These are the gold standard of medical research. Some women got vitamin D supplements. Others got a placebo or no treatment at all.

The key measurement was a hormone called AMH (anti-Müllerian hormone). Doctors use AMH as a rough estimate of how many eggs a woman has left. Think of it like a fuel gauge for your ovaries.

The result was clear. Vitamin D supplements did not raise AMH levels in the group as a whole.

In fact, the numbers pointed in the opposite direction. The overall effect was a small negative change. But that change was not statistically significant. In plain English, vitamin D did not help. And it might have caused a tiny dip, though the data could not prove that for sure.

The Surprising Twist in Women With Higher AMH

Here is where things get interesting.

When researchers looked closer, they found something unexpected. In women who started with AMH levels above 6 ng/mL (a sign of higher egg reserve), vitamin D supplements were linked to a noticeable drop in AMH.

This does not mean vitamin D is dangerous. But it does suggest that more is not always better. The ovaries may have their own way of regulating things.

Think of it like watering a plant. If the soil is already moist, adding more water does not help. It might even cause problems.

How Vitamin D Works in the Body

Vitamin D acts like a key that fits into locks all over your body. Those locks are called receptors. Your ovaries have these locks too.

Scientists thought that turning those locks with vitamin D would help the ovaries work better. But the body is more complex than a simple lock and key system.

Your ovaries make AMH based on many signals. Vitamin D is just one piece of a much larger puzzle. And this research suggests it may not be the most important piece.

The Catch You Need to Know

This does not mean vitamin D is useless for fertility.

The study looked at one specific hormone. It did not measure pregnancy rates, live births, or overall fertility. AMH is a useful marker, but it is not the whole story.

Also, the trials varied quite a bit. Some were double-blind (the best quality). Others were open-label (women knew they were getting vitamin D). When researchers looked only at the double-blind trials, the negative effect disappeared.

This matters because open-label trials can be influenced by what people expect to happen.

If you are taking vitamin D hoping to boost your egg count, this research suggests you may want to rethink that plan.

But do not throw away your vitamin D bottle just yet. Many women are genuinely deficient in vitamin D. And vitamin D is essential for bone health, immune function, and overall well-being.

The takeaway is simple. Take vitamin D if your doctor says your levels are low. But do not expect it to be a fertility booster.

The Limits of This Research

This analysis has some important limitations.

The 11 trials were quite different from each other. Some used high doses of vitamin D. Others used low doses. Some lasted a few weeks. Others lasted several months. This variety makes it harder to draw firm conclusions.

Also, the total number of women was modest at 992. And the quality of the evidence was rated as moderate, not high.

What Happens Next

Researchers will need to do more work to understand the relationship between vitamin D and fertility.

Future studies should focus on specific groups of women. Those with known vitamin D deficiency. Those with polycystic ovary syndrome (PCOS). Those undergoing fertility treatments like IVF.

For now, the message is honest and clear. Vitamin D supplements are not a shortcut to better egg health. If you have concerns about your fertility, talk to your doctor. They can check your vitamin D levels and your AMH levels. And they can help you make a plan that is based on real evidence, not hope alone.

Science takes time. And sometimes the answer is not what we expected. But knowing what does not work is just as valuable as knowing what does.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
BackgroundVitamin D has been implicated in ovarian physiology, yet its effect on ovarian reserve remains controversial. We performed a meta-analysis of randomized controlled trials (RCTs) to evaluate the influence of vitamin D supplementation on ovarian reserve as indicated by serum anti-Müllerian hormone (AMH) levels.MethodsPubMed, Cochrane Library, Embase, Web of Science, Wanfang, and CNKI were searched for RCTs comparing vitamin D supplementation with placebo or no intervention on AMH in women of reproductive age. The pooled effect was summarized as standardized mean difference (SMD) using a random-effects model by incorporating the influence of potential heterogeneity.ResultsEleven RCTs with 992 women were included. Overall, vitamin D supplementation did not significantly affect serum AMH levels (SMD: −0.20; 95% CI: −0.48 to 0.08; p = 0.16), with substantial heterogeneity (I² = 77%, p < 0.001). Subgroup analysis showed no significant effect in double-blind trials but a reduction in AMH in open-label trials (p for subgroup difference = 0.02). A significant interaction was observed according to baseline AMH level (p = 0.003), with a reduction in studies where baseline AMH > 6 ng/mL (SMD: −0.55; 95% CI: −0.87 to −0.23). No significant subgroup differences were found by age, baseline 25(OH)D, vitamin D dose, treatment duration, or assay method.ConclusionsCurrent randomized evidence suggests that vitamin D supplementation was not likely to alter AMH levels in reproductive-aged women overall. The certainty of evidence was moderate, and findings should be interpreted cautiously given substantial heterogeneity.Systematic Review Registrationhttps://www.crd.york.ac.uk/prospero/, identifier CRD420261329210.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.